← All indications
Skin Ulcer
An ULCER of the skin and underlying tissues.
Subtype terms (4)
More specific conditions that are subtypes of Skin Ulcer in the MeSH hierarchy.
- Buruli Ulcer
7 drugs (5 approved, 2 experimental)
- Leg Ulcer
54 drugs (18 approved, 36 experimental)
- Pressure Ulcer
52 drugs (20 approved, 32 experimental)
- Pyoderma Gangrenosum
18 drugs (12 approved, 6 experimental)
Drugs by status
Approved for this indication (1)
Phase 2 trials (5)
Phase 1 trials (1)
Other trials (3)
Organizations
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (27)
- Bayer
- Factor Therapeutics Ltd.
- FGK Clinical Research GmbH
- Nitric BioTherapeutics, Inc
- Parexel
- Rheacell GmbH & Co. KG
- ZonMw: The Netherlands Organisation for Health Research and Development
- Boston University
- Gunma University
- University of Michigan
- University of Tehran
- University of Tennessee
- Utrecht University
- Cardiff University
- Tel Aviv University
- Icahn School of Medicine at Mount Sinai
- University of North Carolina at Chapel Hill
- Humboldt University
- University of Illinois at Chicago
- Grenoble Alps University
- TICEBA GmbH
- Granzer Regulatory Consulting & Services
- ARANZ Medical
- Almac Clinical Services LLC
- University of Grenoble
- Shiraz University
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Würzburg, Germany
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (3)